For the three and six months ended June 30, 2026 and 2025, diluted weighted average common shares outstanding are equal to basic weighted average common shares due to the net loss position of the Company.

The following potentially dilutive securities outstanding had an antidilutive impact and were therefore excluded from the computation of diluted weighted-average shares outstanding:


	For the Three and Six Months Ended June 30,
	2026		2025
Options to purchase common stock		9,279,218		8,605,370
Nonvested restricted stock units		89,808		364,567
Total of common stock equivalents		9,369,026		8,969,937